| Dr James T Heywood, MD | |
|
9898 Genesee Ave, La Jolla, CA 92037-1205 | |
| (858) 824-5333 | |
| Not Available |
| Full Name | Dr James T Heywood |
|---|---|
| Gender | Male |
| Speciality | Advanced Heart Failure And Transplant Cardiology |
| Experience | 44 Years |
| Location | 9898 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285612457 | NPI | - | NPPES |
| 00G461030 | Medicaid | CA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Scripps Memorial Hospital La Jolla | La jolla, CA | Hospital |
| Scripps Green Hospital | La jolla, CA | Hospital |
| Cedars-sinai Medical Center | Los angeles, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scripps Health | 9234033853 | 1362 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16. The study will be discussed on the last day of the Health Protection Agency annual conference in Warwick.
Though much of the dust-up following the Supreme Court's Medicaid decision has come from Republican governors vowing to opt out of the expansion, news outlets report that some Democratic governors also have concerns. Meanwhile, Kentucky became the 13th state to say it would set up its own online insurance exchange where individuals and small businesses could shop for coverage beginning in 2014.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at the University of Oslo and Oslo University Hospital have found the genetic cause of a previously undescribed disease. With this, they have solved an over ten year old medical conundrum.
› Verified 4 days ago
| Entity Name | Scripps Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881636108 PECOS PAC ID: 9234033853 Enrollment ID: O20031124000822 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16. The study will be discussed on the last day of the Health Protection Agency annual conference in Warwick.
Though much of the dust-up following the Supreme Court's Medicaid decision has come from Republican governors vowing to opt out of the expansion, news outlets report that some Democratic governors also have concerns. Meanwhile, Kentucky became the 13th state to say it would set up its own online insurance exchange where individuals and small businesses could shop for coverage beginning in 2014.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at the University of Oslo and Oslo University Hospital have found the genetic cause of a previously undescribed disease. With this, they have solved an over ten year old medical conundrum.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James T Heywood, MD 10790 Rancho Bernardo Rd, San Diego, CA 92127-5705 Ph: (858) 824-5333 | Dr James T Heywood, MD 9898 Genesee Ave, La Jolla, CA 92037-1205 Ph: (858) 824-5333 |
News Archive
Findings published in Diabetes Care from a 12-week, Phase IIb dose-ranging study showed that dapagliflozin, a novel, selective, sodium glucose co-transporter2 (SGLT2) inhibitor, produced clinically meaningful reductions across all key glycemic measures studied [glycosylated hemoglobin level (HbA1c), fasting plasma glucose (FPG), and postprandial plasma glucose (PPG)] in treatment-naive type 2 diabetes patients, compared to placebo.
A new study by the Health protection Agency estimates at least 10% of young women in England have been infected with one or more strains of the human papillomavirus (HPV) by the age of 16. The study will be discussed on the last day of the Health Protection Agency annual conference in Warwick.
Though much of the dust-up following the Supreme Court's Medicaid decision has come from Republican governors vowing to opt out of the expansion, news outlets report that some Democratic governors also have concerns. Meanwhile, Kentucky became the 13th state to say it would set up its own online insurance exchange where individuals and small businesses could shop for coverage beginning in 2014.
A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD).
Researchers at the University of Oslo and Oslo University Hospital have found the genetic cause of a previously undescribed disease. With this, they have solved an over ten year old medical conundrum.
› Verified 4 days ago
Dr. John Sturdivant Andrews, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1223 Via Barranca, La Jolla, CA 92037 Phone: 858-775-1976 | |
Dr. Mark C Adrian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 355, La Jolla, CA 92037 Phone: 858-202-0011 | |
Dr. Erminia M. Guarneri, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-3330 Fax: 858-784-5933 | |
Dr. Eric Hong, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave, Suite 300, La Jolla, CA 92037 Phone: 858-824-2900 Fax: 858-824-2910 | |
Katrina Deleon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 | |
Abhishek Gadre, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9300 Campus Point Dr, La Jolla, CA 92037 Phone: 858-657-7118 | |
Kamran Hussain Imam, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-6158 |